Soluble CD93 as a Novel Biomarker in Asthma Exacerbation
نویسندگان
چکیده
منابع مشابه
Soluble CD93 as a Novel Biomarker in Asthma Exacerbation
Asthma research is shifting from studying symptoms and lung functions to the narrow-focus cellular profiles protein analysis, biomarkers, and genetic markers. The transmembrane glycoprotein CD93 is involved in endothelial cell migration, angiogenesis, leukocytes extravasation, apoptosis, innate immunity and inflammation. Relationships between the serum level of soluble CD93 (sCD93) and acute my...
متن کاملSoluble CD93 in Serum as a Marker of Allergic Inflammation
PURPOSE CD93 is receiving renewed attention as a biomarker of inflammation. We aimed to evaluate the potential for serum sCD93 to serve as a novel biomarker for allergic inflammation. MATERIALS AND METHODS We enrolled 348 subjects with an allergic disease [allergic rhinitis (AR), chronic spontaneous urticaria (CSU), or bronchial asthma (BA)], including 14 steroid-naïve BA patients who were se...
متن کاملSoluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD
BACKGROUND Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory condition, and progresses with acute exacerbations. (AE). During AE, levels of acute phase reactants such as C-reactive protein (CRP) and inflammatory cells in the circulation increase. Soluble urokinase-type plasminogen activator receptor (suPAR) levels increase in acute viral and bacterial infections and in dise...
متن کاملSoluble CD 163: A novel biomarker
monocytes and macrophages by proand antiinflammatory stimuli. J Leukoc Biol 2000;67:97-103. 4. Moestrup SK, Moller HJ. CD163. A regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 2004;36:347-54. 5. Droste A, Sorg C, Hogger P. Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteinerich family. Biochem Biophys Res...
متن کاملSerum Myeloperoxidase as A Biomarker of Asthma Severity Among Adults: A Case Control Study
Background: The contribution of neutrophils is still indistinct in the inflammatory response of bronchial asthma (BAs). Myeloperoxidase (MPO) is an enzyme released from the primary azurophilic granules of the neutrophils. The study aimed to evaluate the levels of serum MPO as a biomarker for the assessment of the level of asthma control. Methods: The study participants included 94 asthmat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Allergy, Asthma & Immunology Research
سال: 2016
ISSN: 2092-7355,2092-7363
DOI: 10.4168/aair.2016.8.5.461